A phase I/II trial of infusional arsenic trioxide for relapsed acute promyelocytic leukemia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Arsenic trioxide (Primary)
- Indications Acute promyelocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 12 Apr 2013 Biomarkers information updated
- 25 Sep 2005 New trial record.